These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9514399)

  • 21. Two novel mutations in exon 3 and 4 of low density lipoprotein (LDL) receptor gene in patients with heterozygous familial hypercholesterolemia.
    Khan SP; Ghani R; Ahmed KZ; Yaqoob Z
    J Coll Physicians Surg Pak; 2011 Jul; 21(7):403-6. PubMed ID: 21777527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homozygous Familial Hypercholesterolemia in Spain: Prevalence and Phenotype-Genotype Relationship.
    Sánchez-Hernández RM; Civeira F; Stef M; Perez-Calahorra S; Almagro F; Plana N; Novoa FJ; Sáenz-Aranzubía P; Mosquera D; Soler C; Fuentes FJ; Brito-Casillas Y; Real JT; Blanco-Vaca F; Ascaso JF; Pocovi M
    Circ Cardiovasc Genet; 2016 Dec; 9(6):504-510. PubMed ID: 27784735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prenatal diagnosis of familial hypercholesterolemia: importance of DNA analysis in the high-risk South African population.
    Vergotine J; Thiart R; Langenhoven E; Hillermann R; De Jong G; Kotze MJ
    Genet Couns; 2001; 12(2):121-7. PubMed ID: 11491306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
    Ferrières J; Bruckert É; Béliard S; Rabès JP; Farnier M; Krempf M; Cariou B; Danchin N
    Ann Cardiol Angeiol (Paris); 2018 Feb; 67(1):1-8. PubMed ID: 28576280
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of gene mutations allows for the molecular diagnosis of familial hypercholesterolemia.
    Retief AE; Kotze MJ; Oosthuizen CJ
    S Afr Med J; 1989 Aug; 76(3):121. PubMed ID: 2762943
    [No Abstract]   [Full Text] [Related]  

  • 26. Multicenter study to determine the diagnosis criteria of heterozygous familial hypercholesterolemia in Japan.
    Harada-Shiba M; Arai H; Okamura T; Yokote K; Oikawa S; Nohara A; Okada T; Ohta T; Bujo H; Watanabe M; Wakatsuki A; Yamashita S
    J Atheroscler Thromb; 2012; 19(11):1019-26. PubMed ID: 23095241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Cardiovascular Risk in Heterozygous Familial Hypercholesterolemia Relatives Identified by Cascade Screening.
    Kjærgaard KA; Christiansen MK; Schmidt M; Olsen MS; Jensen HK
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28652386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of mutations and genetherapy. Clinical genetics of familial hypercholesterolemia.
    Schuster H
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():4-5. PubMed ID: 8767443
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia.
    Athyros VG; Papageorgiou AA; Kontopoulos AG
    Atherosclerosis; 2002 Jul; 163(1):205-6. PubMed ID: 12048142
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical manifestations of heterozygote familial hypercholesterolemia in Spain. Study of 301 cases from the central and northern areas].
    Garcés C; Rodríguez Artalejo F; Serrano A; González Bonillo J; Almagro F; Garrido JA; Zúñiga M; de Oya M
    Med Clin (Barc); 2000 Jan; 114(2):50-1. PubMed ID: 10702948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining the challenges of familial hypercholesterolemia screening: introduction.
    Hopkins PN
    J Clin Lipidol; 2010; 4(5):342-5. PubMed ID: 21122675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analysis in a compound heterozygote family with familial hypercholesterolemia.
    Wang F; Fan Q; Tao R; Gu G; Zhang R; Xi R
    Mol Med Rep; 2018 Jun; 17(6):8439-8449. PubMed ID: 29693183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-density lipoprotein cholesterol-lowering effects of AMG 145, a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease in patients with heterozygous familial hypercholesterolemia: the Reduction of LDL-C with PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder (RUTHERFORD) randomized trial.
    Raal F; Scott R; Somaratne R; Bridges I; Li G; Wasserman SM; Stein EA
    Circulation; 2012 Nov; 126(20):2408-17. PubMed ID: 23129602
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial hypercholesterolemia: report of coronary death at age 3 in a homozygous child and prenatal diagnosis in a heterozygous sibling.
    Rose V; Wilson G; Steiner G
    J Pediatr; 1982 May; 100(5):757-9. PubMed ID: 7069536
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of DNA array platform vs DNA sequencing as genetic diagnosis tools for familial hypercholesterolemia.
    Tejedor D; Castillo S; Mozas P; Jiménez E; López M; Tejedor MT; Artieda M; Alonso R; Mata P; Simón L; Martínez A; Pocoví M
    Clin Chem; 2006 Oct; 52(10):1971-2. PubMed ID: 16998121
    [No Abstract]   [Full Text] [Related]  

  • 36. [Heterozygous familial hypercholesterolemia: the first challenge for anti-PCSK9 monoclonal antibodies].
    Zambon A
    G Ital Cardiol (Rome); 2016 Apr; 17(4 Suppl 1):22S-30. PubMed ID: 27312020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High specificity makes DNA screening the method of choice for diagnosis of familial hypercholesterolaemia.
    Kotze MJ
    S Afr Med J; 2001 Dec; 91(12):1042. PubMed ID: 11845598
    [No Abstract]   [Full Text] [Related]  

  • 38. Seven DNA polymorphisms in the LDL receptor gene: application to the study of familial hypercholesterolemia in Spain.
    Chaves FJ; Puig O; García-Sogo M; Real J; Gil JV; Ascaso J; Carmena R; Armengod ME
    Clin Genet; 1996 Jul; 50(1):28-35. PubMed ID: 8891383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic variation and its correlation with mutations in the low density lipoprotein (LDL) receptor gene in familial hypercholesterolemia.
    Sun XM; Neuwirth C; Patel DD; Knight BL; Soutar AK
    Z Gastroenterol; 1996 Jun; 34 Suppl 3():12-3. PubMed ID: 8767446
    [No Abstract]   [Full Text] [Related]  

  • 40. Familial hypercholesterolemia--we must act boldly.
    Moodie D
    Congenit Heart Dis; 2014; 9(4):273-4. PubMed ID: 25099345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.